Quantitative Analysis of Minimal Residual Disease (MRD) Shows High Rates of Undetectable MRD after Fixed-Duration Chemotherapy-Free Treatment and Serves As Surrogate Marker for Progression-Free Survival: A Prospective Analysis of the Randomized CLL14 Trial

K Fischer, M Ritgen, O Al-Sawaf, S Robrecht, M Tandon, A M Fink, A Schilhabel, T Stübig, M Brüggemann, Y Jiang, W Schary, BF Eichhorst, CM Wendtner, E Tausch, KA Kreuzer, Ton Langerak, V Goede, S Böttcher, S Stilgenbauer, M KnebaM Hallek

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)36
Issue number1
Publication statusPublished - 2019

Cite this